Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5175488
Max Phase: Preclinical
Molecular Formula: C61H72BF2N9O8S
Molecular Weight: 1140.18
Associated Items:
ID: ALA5175488
Max Phase: Preclinical
Molecular Formula: C61H72BF2N9O8S
Molecular Weight: 1140.18
Associated Items:
Canonical SMILES: C[C@@H](NC(=O)CCN1CCC(Oc2ccccc2Cc2ccccc2)CC1)C(=O)N[C@H](C)C(=O)N[C@H](C)C(=O)NCCNC(=O)CCCCCNC(=O)COc1ccc(/C=C/C2=[N+]3C(=Cc4ccc(-c5cccs5)n4[B-]3(F)F)C=C2)cc1
Standard InChI: InChI=1S/C61H72BF2N9O8S/c1-42(69-61(79)44(3)70-60(78)43(2)68-57(75)31-37-71-35-29-52(30-36-71)81-54-16-10-9-15-47(54)39-46-13-6-4-7-14-46)59(77)67-34-33-66-56(74)18-8-5-11-32-65-58(76)41-80-51-26-20-45(21-27-51)19-22-48-23-24-49-40-50-25-28-53(55-17-12-38-82-55)73(50)62(63,64)72(48)49/h4,6-7,9-10,12-17,19-28,38,40,42-44,52H,5,8,11,18,29-37,39,41H2,1-3H3,(H,65,76)(H,66,74)(H,67,77)(H,68,75)(H,69,79)(H,70,78)/b22-19+/t42-,43-,44-/m1/s1
Standard InChI Key: CSVVEXGAAAWMNF-QHMXGELZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1140.18 | Molecular Weight (Monoisotopic): 1139.5286 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Kok ZY, Stoddart LA, Mistry SJ, Mocking TAM, Vischer HF, Leurs R, Hill SJ, Mistry SN, Kellam B.. (2022) Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H1 Receptor., 65 (12.0): [PMID:35734860] [10.1021/acs.jmedchem.2c00125] |
Source(1):